Nuvelo Takes in $74.8M in Gross Proceeds from Common Stock Offering | GenomeWeb

Nuvelo Takes in $74.8M in Gross Proceeds from Common Stock Offering

Mar 09, 2004

NEW YORK, March 9 (GenomeWeb News) - Nuvelo has completed its common stock offering, resulting in approximately $74.8 million in gross proceeds, the company said yesterday.

Nuvelo sold 5.75 million shares in total, including 5 million shares from its public offering and 750,000 shares offered to underwriters as an option.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Alan Rabson Dies

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

ECRI Institute to Offer Medical Guidelines

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

This Week in Genome Research

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

Places to Talk About It

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.